Daxor Price to Sales Ratio 2012-2011 | DXR

Historical PS ratio values for Daxor (DXR) over the last 10 years. The current P/S ratio for Daxor as of June 12, 2026 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Daxor P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2026-06-12 9.26 27.03
2011-12-31 8.59 $0.34 25.07
2011-09-30 9.87 $0.34 29.00
2011-06-30 9.51 $0.37 25.96
2011-03-31 9.45 $0.37 25.63
2010-12-31 8.52 $0.37 22.88
2010-09-30 7.96 $0.39 20.17
2010-06-30 8.51 $0.38 22.10
2010-03-31 9.44 $0.39 24.38
2009-12-31 10.09 $0.40 25.53
2009-09-30 9.14 $0.36 25.13
2009-06-30 7.89 $0.37 21.30
2009-03-31 11.72 $0.41 28.74
2008-12-31 11.57 $0.40 28.80
2008-09-30 11.27 $0.43 26.29
2008-06-30 10.87 $0.40 27.10
2008-03-31 9.14 $0.39 23.26
2007-12-31 10.03 $0.41 24.62
2007-09-30 10.80 $0.38 28.62
2007-06-30 10.46 $0.39 26.69
2007-03-31 9.09 $0.36 25.46
2006-12-31 10.18 $0.32 31.70
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.048B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
U.S Physical Therapy (USPH) United States $1.157B 29.19
Pennant (PNTG) United States $1.072B 31.31
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00